By Roshan Fernandez
Shares of Sanara MedTech declined after the company said it is seeking partners to invest in its wound care program.
The surgical product manufacturer's stock was down 5.7% to $33.10 in Wednesday trading. Shares are down less than 1% this year.
Chief Executive Ron Nixon said the company's Tissue Health Plus team is preparing to launch a pilot program with a wound care provider group later in the second quarter, while pursuing financial partners to invest in the execution of its strategy.
The Fort Worth, Texas-based company reported a wider first-quarter loss of $3.5 million, or 41 cents a share, compared with a loss of $1.8 million, or 21 cents a share, a year earlier.
Revenue rose to $23.4 million from $18.5 million during the year-ago quarter.
Sales for soft-tissue repair products grew 28%, year over year, and sales of bone fusion products were up 18%.
Nixon said the company's surgical segment had a strong quarter. That growth reflected progress in developing the company's network of distributor partners, adding new healthcare facility customers, and increasing penetration of existing facility customers, he said.
Write to Roshan Fernandez at roshan.fernandez@wsj.com
(MORE TO FOLLOW) Dow Jones Newswires
May 14, 2025 13:29 ET (17:29 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。